XpertDox and Nao Medical Announce Partnership to Transform Revenue Cycle and Improve Clinical Documentation Through AI-Driven Innovation

XpertDox partners with Nao Medical to integrate its AI medical coding software and XpertCoding Business Intelligence Platform for AI medical coding to improve clinical documentation and RCM workflows.

SCOTTSDALE, Ariz., Jan. 2, 2025 /PRNewswire/ — XpertDox, a leader in AI-powered autonomous medical coding solutions, has partnered with Nao Medical, a multi-specialty healthcare provider in New York, to integrate its cutting-edge AI medical coding software, XpertCoding, and its Business Intelligence (BI) Platform into Nao Medical’s revenue cycle management (RCM) operations. This collaboration aims to minimize claim denials, enhance clinical documentation, improve charge capture, and ensure workflow compliance.

Nao Medical is a pioneer in delivering personalized, tech-enabled Primary Care, Urgent Care, Mental Health, Women’s Health, Nutrition, and Virtual Care services. By prioritizing accessible, high-quality, affordable healthcare, Nao Medical meets both routine and urgent healthcare needs with efficiency and compassion.

A Partnership Delivering Measurable Impact
Arihant Jain, President of Nao Medical, shared the significant improvements the partnership has brought: “With XpertCoding, we’ve achieved a 15% increase in charge capture, a 60% increase in quality code capture, a 40% reduction in charge entry lag, ensuring claims are processed within 24 hours, and a 22% reduction in claim denials. These advancements have strengthened our revenue cycle management and enabled us to focus on delivering exceptional care to our patients.

XpertCoding: Empowering Financial Stability Through Intelligence
The XpertCoding Business Intelligence Platform provides Nao Medical with real-time analytics and actionable insights into coding workflows. This empowers leadership to monitor KPIs, streamline claim automation, and address coding inefficiencies to ensure long-term financial stability. Its Clinical Documentation Improvement (CDI) module enhances coding accuracy, reduces errors, and optimizes workflow efficiency, paving the way for sustained operational improvements.

Dr. Sameer Ather, CEO of XpertDox, highlighted the broader vision for the partnership: “Our collaboration with Nao Medical demonstrates the transformative potential of AI in healthcare. By integrating our AI medical coding software and Business Intelligence Platform, we’ve delivered measurable financial improvements, allowing Nao Medical to focus on its core missionproviding exceptional, personalized patient care.

Based in Scottsdale, Arizona, XpertDox specializes in AI-driven data analytics, autonomous medical coding software, and business intelligence platforms. Its solutions are designed to optimize charge recovery, enhance clinical documentation, and improve revenue cycle management for healthcare organizations.

For more information about XpertDox’s AI medical coding software and Business Intelligence Platform, contact info@xpertdox.com or visit www.xpertdox.com.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xpertdox-and-nao-medical-announce-partnership-to-transform-revenue-cycle-and-improve-clinical-documentation-through-ai-driven-innovation-302340717.html

SOURCE XpertDox

Staff

Recent Posts

The 2025 Black Book of Physician Practice Management Technology Released: A Competitive Intelligence Report

Free to participants in the 2025 survey of PM software, this comprehensive report offers critical…

56 minutes ago

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc.,…

56 minutes ago

The 2025 Black Book of Physician Practice Management Technology Released: A Competitive Intelligence Report

Free to participants in the 2025 survey of PM software, this comprehensive report offers critical…

56 minutes ago

Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase

SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today…

56 minutes ago

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading…

56 minutes ago

Ensysce Biosciences Issues Annual Shareholder Letter

~ FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~…

56 minutes ago